Felipe Yadav

Angel Investor & Venture Capitalist | Life Sciences, Biotech & Health Innovation | Strategic Advisor to Disruptive Startups | Deep Tech & Healthcare Investor

📍 United Kingdom🔄 Updated September 2026💼 8 investments📅 18 years investing🗓 Last invested Feb 2023
VC🌍 United Kingdom
8
Total investments
4
Early stage
2
Mid stage
1
Late stage
18y
Years active

Portfolio

7 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Feb 2023
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.
Investor
2023
FasterCapital is a global venture builder and online incubator dedicated to co-funding and co-founding innovative startups. Established in 2014, we are now #1 venture builder in terms of number of startups that we have helped, money invested and money raised. We have supported over 1129 startups in raising more than $2.5 billion, while directly investing over $696 million in 288 companies. Our comprehensive support system includes a worldwide network of mentors, investors, and strategic partners, allowing us to transform ideas into scalable, market-ready businesses. 🚀 What We Do We co-build and fund startups through our key programs: Raise Capital: Connect founders with global investors and support fundraising, valuations, and negotiations. Tech Cofounder: Build MVPs and full-scale products, turning ideas into market-ready solutions. Grow Your Startup: Drive marketing, sales, and business expansion for sustainable growth. Franchise Program: Help businesses scale by replicating successful models into new markets. Real Estate Program: Enable innovation and investment in prop-tech and real estate ventures. IP Program: Protect, manage, and monetize intellectual property for startups and entrepreneurs. UAE Company Creation: Guide founders to start and establish businesses in the UAE with full legal and operational support. FasterCapital’s online presence is massive — with 40 million visits monthly, and a domain authority of 80. 📚 LearnHub — Our Knowledge Powerhouse FasterCapital proudly presents LearnHub, our comprehensive learning platform covering capital raising, investment, business, and entrepreneurship. LearnHub houses: 5+ million articles 7 million topics 1 million keywords 1.5 million Q&A entries 100 million images & infographics LearnHub is regularly cited across leading business media — featured on outlets like Wikipedia, Investopedia, Nasdaq, Entrepreneur, Fortune, Time, Yahoo, Bloomberg, Forbes, Inc., and many more.
Investor
May 2020
Telemedicine provider of online healthcare delivery services using a secure platform via video, audio, email and integrated with mobile devices. The solution platform let patients and doctors carry out medical consultations with no restrictions regarding to locations and timing.
Investor
2017
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
Investor
Mar 2015
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Angel Investor
2010
Productboard is the intelligent product management platform that helps future-ready product teams deliver exceptional products with clarity and confidence. Over 6,000 companies, including Zoom, One Medical, Cartier, Microsoft, and Korn Ferry, use Productboard to uncover customer needs, drive strategic alignment, and rally everyone around the roadmap. With offices in Prague and San Francisco, Productboard is backed by leading investors like Dragoneer Investment Group, Tiger Global Management, Index Ventures, Kleiner Perkins, Sequoia Capital, Bessemer Venture Partners, and Credo Ventures.
Investor
May 2008
Quartzy is a cloud-based platform that allows laboratories to streamline their communications, manage inventory, and purchase what they need to hit their milestones faster. Watch the video: https://bit.ly/3kQzREz
Experience · 11 entries
All (11)
Investments (8)
2023
Investor
Feb 2023
Rapport Therapeutics aims to transform the treatment of neurological disorders through a precision medicine approach, precisely targeting disease-driving neurocircuits by leveraging receptor-associated proteins (RAPs). With this approach, Rapport can overcome the well-established limitations of today’s neuromedicines that act indiscriminately throughout the nervous system, resulting in suboptimal efficacy and burdensome side effects. Leading the hunt for precision medicines is a team with established track records of innovation in neuroscience and drug discovery. Rapport was conceptualized and created through a partnership between Third Rock Ventures and Johnson & Johnson Innovation-JJDC, Inc. (JJDC) and launched in March 2023. Rapport is based in San Diego, CA and Boston, MA. For more information, please visit www.rapportrx.com.
Investor
2023
FasterCapital is a global venture builder and online incubator dedicated to co-funding and co-founding innovative startups. Established in 2014, we are now #1 venture builder in terms of number of startups that we have helped, money invested and money raised. We have supported over 1129 startups in raising more than $2.5 billion, while directly investing over $696 million in 288 companies. Our comprehensive support system includes a worldwide network of mentors, investors, and strategic partners, allowing us to transform ideas into scalable, market-ready businesses. 🚀 What We Do We co-build and fund startups through our key programs: Raise Capital: Connect founders with global investors and support fundraising, valuations, and negotiations. Tech Cofounder: Build MVPs and full-scale products, turning ideas into market-ready solutions. Grow Your Startup: Drive marketing, sales, and business expansion for sustainable growth. Franchise Program: Help businesses scale by replicating successful models into new markets. Real Estate Program: Enable innovation and investment in prop-tech and real estate ventures. IP Program: Protect, manage, and monetize intellectual property for startups and entrepreneurs. UAE Company Creation: Guide founders to start and establish businesses in the UAE with full legal and operational support. FasterCapital’s online presence is massive — with 40 million visits monthly, and a domain authority of 80. 📚 LearnHub — Our Knowledge Powerhouse FasterCapital proudly presents LearnHub, our comprehensive learning platform covering capital raising, investment, business, and entrepreneurship. LearnHub houses: 5+ million articles 7 million topics 1 million keywords 1.5 million Q&A entries 100 million images & infographics LearnHub is regularly cited across leading business media — featured on outlets like Wikipedia, Investopedia, Nasdaq, Entrepreneur, Fortune, Time, Yahoo, Bloomberg, Forbes, Inc., and many more.
2022
Chief Business Officer
Aug 2022
The Kings Fund is an independent charity working to improve peoples health. Our vision is a world where everyone can live a healthy life. Our mission is to inspire hope and build confidence for positive change. We achieve this through expert insights and original research, developing leaders and their organisations, convening, and strategic, collaborative partnerships.
Advisor
2022
GV supports innovative founders across multiple stages and sectors, from artificial intelligence and life sciences to consumer platforms, enterprise software, and frontier technology. Launched as Google Ventures in 2009, GV oversees more than $10 billion in assets under management. Our operating partners support founding teams at every stage of company-building across executive talent, design, communications, and marketing. GV is a non-strategic venture capital firm that invests independently from its sole limited partner, Alphabet. We connect startups with Google and Alphabet companies, providing unique access to the world’s best technology and talent. GV has 400 active portfolio companies spanning North America, Europe, and Israel. Our portfolio includes Lightmatter, Stripe, Treeline Biosciences, Vercel, and Wonder, with notable exits including Uber, Nest, Slack, GitLab, Duo Security, Flatiron Health, Lemonade, and One Medical. The firm is headquartered in the San Francisco Bay Area, with offices in Cambridge, New York, and London.
2020
Investor
May 2020
Telemedicine provider of online healthcare delivery services using a secure platform via video, audio, email and integrated with mobile devices. The solution platform let patients and doctors carry out medical consultations with no restrictions regarding to locations and timing.
Show all 11 entries ↓
Investment activity
2008–2023 · 8 investments
20081201012015120171201912020120232
Recent (last 2 years)Earlier